Evidence map›Paper›PMID 38217550›Full record

ArticleInternational journal of geriatric psychiatry2024

The risk of developing dementia in the COVID-19 pandemic; a cohort study.

Daniel Hendrik Baron, Elizabeth Coulthard, Carslake David, Lindsey Isla Sinclair

Open access · hybridAbstract read
In one paragraph

Article in International journal of geriatric psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. The risk of developing dementia in the COVID-19 pandemic; a cohort study.International journal of geriatric psychiatry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Daniel Hendrik BaronDementia Research Group, University of Bristol, Bristol, UK.ORCID 0000-0001-5364-211X
Elizabeth CoulthardReMemBr Group, University of Bristol, Bristol, UK.
Carslake DavidPopulation Health Sciences, University of Bristol, Bristol, UK.
Lindsey Isla SinclairDementia Research Group, University of Bristol, Bristol, UK.ORCID 0000-0002-4776-4118
University of Bristol · GBFrimley Health NHS Foundation Trust · GB

Funding

Alzheimer's SocietyMedical Research Council MR/L023784/2Wellcome Trust
6 · The paper itself

Abstract

objectivesThe effects of the COVID-19 pandemic on cognitive decline are not fully understood. Higher social activity and relationships have been associated with decreased risk of dementia. We hypothesised that risk of transition to dementia would increase after the start of the first national lockdown.

methodsWe obtained data from the Brains for Dementia (BDR) cohort, which has collected roughly annual data on 3726 older adults with and without dementia since 2008. Data continued to be collected during the lockdowns, although by telephone and/or video call instead of in person. Individuals diagnosed with dementia at study entry were excluded from this study as were individuals with only one visit. Cognitive status was classified using the Clinical Dementia Rating (CDR) global score. Poisson regression with cubic splines to account for differences in age was used to compare the incidence of dementia before and after March 1st 2020.

resultsOut of 2242 individuals, 208 individuals developed dementia before and 50 developed dementia after 01/03/20. The incidence rate ratio of developing dementia after 01/03/20 was 0.847 (0.538-1.335) p = 0.570. In our secondary analysis we found that the positive association between mild cognitive impairment (MCI) and dementia incidence decreased after 1/3/20 (interaction effect p = 0.031).

conclusionThe incidence of dementia as defined using the CDR global score did not change significantly after the first lockdown began, but we found evidence that lockdown decreased the positive association between MCI and dementia incidence. This may reflect that individuals were progressing to dementia more rapidly and thus missing the MCI stage or that assessing patients over the phone made diagnosing MCI more challenging.

Indexed as

Alzheimer DiseaseCognitive DysfunctionCOVID-19DementiaAgedCohort StudiesCommunicable Disease ControlDisease ProgressionHumansNeuropsychological TestsPandemicsAlzheimer's diseasecognitive dysfunctionCOVID-19mild cognitive impairmentquarantinesars-CoV-2social isolation

Identifiers

PMID38217550
PMCPMC10952166
OpenAlexW4390843341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.